Tremor as the first neurological manifestation of Sneddon's syndrome

Movement Disorders

Volumn 20, Issue 2, 2005, Pages 248-251

  Martins da Silva, Ana ^a   Rocha, N ^a   Pinto, M ^a   Alves, V ^a   Farinha, F ^a   Correia, A P ^a   Coelho, T ^a   Magalhaes M ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Livedo reticularis; Parkinsonian syndrome; Sneddon's syndrome; Tremor

Indexed keywords

ACENOCOUMAROL; ANTINUCLEAR ANTIBODY; CAPTOPRIL; CLONAZEPAM; HEPARIN; LEVODOPA; PHENOBARBITAL; PRIMIDONE;

ADULT; ANAMNESIS; ANTIBODY TITER; ARTICLE; BASAL GANGLION; BRAIN CORTEX; CASE REPORT; CEREBELLUM; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE EXACERBATION; FEMALE; FETUS WASTAGE; HUMAN; HYPERTENSION; LIVEDO RETICULARIS; MEMORY DISORDER; MESENCEPHALON; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; SNEDDON SYNDROME; TREMOR;

ANTICONVULSANTS; BRAIN; CLONAZEPAM; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; LATERAL VENTRICLES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROLOGIC EXAMINATION; PHENOBARBITAL; SNEDDON SYNDROME; TREMOR;

EID: 14944347655     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20270     Document Type: Article

References (26)

1. Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GG, Fritsch PO, Aichner FT. Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke 1993;24:685-690.
2. Champion RH, Rook A. Livedo reticularis. Proc Natl Acad Sci USA 1960;53:961-962.
3. Sneddon IB. Cerebrovascular lesions and livedo reficularis. Br J Dermatol 1965;77:180-185.
4. Kalashnikova LA, Korczyn AD, Shavit S, Rebrova O, Reshetnyak T, Chapman J. Antibodies to prothrombin in patients with Sneddon's syndrome. Neurology 1999;53:223-225.
5. Gantcheva M, Tsankov N. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome. J Eur Acad Dermatol Venereol 1999;12: 157-160.
6. Rauova L, Chapman J, Shoenfeld Y. Brain vasculitis and antiphospholipid syndrome. In: Abramsky O, Compston DAS, Miller A, Said G, editors. Brain disease: therapeutic strategies and repair. London: Martin Dunitz; 2002. p 193-199.
7. Warlow CP, Dennis MS, Van Gijn J, et al. Stroke: a practical guide to management. Oxford: Blackwell Science; 1996.
8. Rebollo M, Val JF, Garijo F, Quintana F, et al. Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases. Brain 1983; 106:965-979.
9. Lubach D, Schwabe C, Weissenbord K, et al. Livedo racemosa generalisata: an evaluation of thirty-four cases. J Am Acad Dermatol 1990;22:633-639.
10. Asherson RA, Khamashta MA, Gil A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989;86:391-399.
11. Zelger B, Sepp N, Stockhammer G, et al. Sneddon's syndrome. Arch Dermatol 1983;129:437-447.
12. Tourbah A, Piette JC, Iba-Zizen MT, Lyon-Caen O, Godeau P, Francès C. The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol 1997;54:53-60.
13. Geschwind D, FitzPatrick M, Michel P, Cummings J. Sneddon's syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology 1995;45:557-560.
14. Wohlrab J, Fischer M, Wolter M, Marsch WC. Diagnostic impact and sensitivity of skin biopsies in Sneddon's syndrome. A report of 15 cases. Br J Dermatol 2001;145:285-288.
15. Hilton D, Footitt D. Neuropathological findings in Sneddon's syndrome. Neurology 2003;60:1181-1182.
16. Devuyst G, Sindic C, Laterre EC, Brucher JM. Neuropathological findings of a Sneddon's syndrome presenting with dementia not preceded by clinical cerebrovascular event (letter). Stroke 1996; 27:1008-1009.
17. Dupont S, Feénelon G, Saiag P, Sirmai J. Warfarin in Sneddon's syndrome (letter). Neurology 1996;46:1781.
18. Floel A, Imai T, Lohmann H, Bethke F, Sunderkotter C, Droste DW. Therapy of Sneddon syndrome. Eur Neurol 2002;48:126-132.
19. Deuschl G, Bain P, Brin M. Consensus statement of Movement Disorder Society on tremor. Ad Hoc Scientific Committee. Movement Disorders 1998;13(Suppl.):2-23.
20. Watts RL, Koller WC. Movement disorders: neurologic principles and practice. New York: McGraw-Hill; 1997.
21. Deuschl G, Raethjen J, Lindemann M, et al. The pathophysiology of tremor. Muscle Nerve 2001;24:716-735.
22. Bain PG. The management of tremor. J Neurol Neurosurg Psychiatry 2002;72:3-9.
23. Rich MW. Sneddon Syndrome and dementia [letter]. Mayo Clin Proc 1999;74:1306.
24. Wright RA, Kokmen E. Gradually progressive dementia without discrete cerebrovascular events in a patient with Sneddon's syndrome. Mayo Clin Proc 1999;74:57-61.
25. Jura E, Palasik W, Meurer M, Palester-Chlebowczyk M, Czlonkowska A. Sneddon's syndrome (livedo, reticularis and cerebrovascular lesions) with antiphospholipid antibodies and severe dementia in a young man: a case report. Acta Neurol Scand 1994;89:143-146.
26. Weissenborn K, Rückert N, Ehrenheim C, Schellong S, Goetz C, Lubach D. Neuropsychological deficits in patients with Sneddon's syndrome. J Neurol 1996;243:357-363.